GeneDx Holdings (WGS) Operating Income (2020 - 2026)
GeneDx Holdings (WGS) reported Operating Income of -$57.5 million for Q1 2026, down 1162.82% year-over-year from $5.4 million in Q1 2025, and down 303.73% quarter-over-quarter from -$14.2 million in Q4 2025.
GeneDx Holdings (WGS) Operating Income (2020 - 2026) Analysis & Trends
GeneDx Holdings (WGS) has 7 years of Operating Income data on file, last reported at -$57.5 million in Q1 2026.
- Operating Income for Q1 2026 came in at -$57.5 million, down 1162.82% year-over-year; the trailing twelve-month figure through Mar 2026 was -$66.0 million (down 367.93% YoY), and the FY2025 annual result was -$13.1 million, up 43.67% from the prior year.
- Operating Income fell to -$57.5 million in Q1 2026 per WGS's latest filing, from -$14.2 million in the prior quarter.
- Over five years, Operating Income peaked at $9.0 million in Q2 2025 and troughed at -$324.9 million in Q4 2022.
- A 5-year average of -$55.4 million and a median of -$25.6 million in 2023 frame the typical range for Operating Income.
- The sharpest annual moves came in 2025 and 2026: Operating Income surged 184.7% in 2025, then plunged 1162.82% in 2026.
- A 5-year view of Operating Income shows it stood at -$324.9 million in 2022, then soared by 92.11% to -$25.6 million in 2023, then jumped by 134.34% to $8.8 million in 2024, then tumbled by 261.65% to -$14.2 million in 2025, then slumped by 303.73% to -$57.5 million in 2026.
- Business Quant data shows WGS's Operating Income at -$57.5 million in Q1 2026, -$14.2 million in Q4 2025, and -$3.3 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 30,529.42 Bn | 30,528.96 Bn | 1.11 Bn | -47.00 Mn |
| 2 | Thermo Fisher Scientific | 183.75 Bn | 180.50 Bn | 7.74 Bn | 1.86 Bn |
| 3 | Danaher | 133.13 Bn | 127.43 Bn | 3.59 Bn | 1.34 Bn |
| 4 | Idexx Laboratories | 46.14 Bn | 45.94 Bn | 722.74 Mn | 362.59 Mn |
| 5 | Agilent Technologies | 38.20 Bn | 36.39 Bn | 990.00 Mn | 399.00 Mn |
| 6 | Natera | 31.50 Bn | 30.40 Bn | 696.04 Mn | -93.52 Mn |
| 7 | Iqvia Holdings | 31.34 Bn | 29.36 Bn | 1.36 Bn | 514.00 Mn |
| 8 | Illumina | 24.51 Bn | 23.36 Bn | 721.00 Mn | 209.00 Mn |
| 9 | Mettler Toledo International | 23.53 Bn | 23.47 Bn | 555.82 Mn | 238.95 Mn |
| 10 | GeneDx Holdings | 1.65 Bn | 1.48 Bn | 68.21 Mn | -57.47 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -57.47 Mn |
| Dec 31, 2025 | -14.24 Mn |
| Sep 30, 2025 | -3.25 Mn |
| Jun 30, 2025 | 8.96 Mn |
| Mar 31, 2025 | -4.55 Mn |
| Dec 31, 2024 | 8.81 Mn |
| Sep 30, 2024 | -7.78 Mn |
| Jun 30, 2024 | -10.58 Mn |
| Mar 31, 2024 | -13.66 Mn |
| Dec 31, 2023 | -25.64 Mn |
| Sep 30, 2023 | -42.97 Mn |
| Jun 30, 2023 | -51.62 Mn |
| Mar 31, 2023 | -60.36 Mn |
| Dec 31, 2022 | -324.88 Mn |
| Sep 30, 2022 | -90.82 Mn |
| Jun 30, 2022 | -162.65 Mn |
| Mar 31, 2022 | -89.31 Mn |
| Dec 31, 2021 | -115.78 Mn |
| Sep 30, 2021 | -88.26 Mn |
| Jun 30, 2021 | -45.45 Mn |